Dr. John Kern, DO

NPI: 1588930879
Total Payments
$1,838
2024 Payments
$668.33
Companies
19
Transactions
57
Medicare Patients
1,093
Medicare Billing
$153,492

Payment Breakdown by Category

Food & Beverage$1,820 (99.0%)
Education$18.28 (1.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,820 56 99.0%
Education $18.28 1 1.0%

Top Paying Companies

Company Total Records Latest Year
Actelion Pharmaceuticals US, Inc. $565.48 15 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $229.90 8 $0 (2023)
AstraZeneca Pharmaceuticals LP $167.77 2 $0 (2024)
GENZYME CORPORATION $157.17 5 $0 (2024)
Ziehm Imaging, Inc. $137.43 2 $0 (2017)
Inari Medical, Inc. $107.18 1 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $86.63 2 $0 (2024)
GlaxoSmithKline, LLC. $72.18 5 $0 (2024)
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $51.92 4 $0 (2023)
Edwards Lifesciences Corporation $41.92 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $668.33 28 AstraZeneca Pharmaceuticals LP ($167.77)
2023 $660.32 15 Actelion Pharmaceuticals US, Inc. ($279.40)
2022 $107.01 8 Bayer HealthCare Pharmaceuticals Inc. ($57.95)
2021 $41.92 1 Edwards Lifesciences Corporation ($41.92)
2019 $222.88 3 Actelion Pharmaceuticals US, Inc. ($152.06)
2017 $137.43 2 Ziehm Imaging, Inc. ($137.43)

All Payment Transactions

57 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/18/2024 GENZYME CORPORATION DUPIXENT (Biological), DUPIXENT Food and Beverage In-kind items and services $118.34 General
Category: Immunology
12/04/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $113.56 General
Category: Respiratory
11/19/2024 SCPHARMACEUTICALS INC. FUROSCIX (Drug) Food and Beverage In-kind items and services $23.88 General
Category: Cardiology
11/18/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Food and Beverage In-kind items and services $15.29 General
Category: Cardiology
11/14/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $19.79 General
Category: Immunology
10/09/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $6.50 General
Category: Immunology
10/01/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $54.21 General
Category: Respiratory
09/27/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Food and Beverage In-kind items and services $15.73 General
Category: Cardiology
09/26/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $2.96 General
Category: Immunology
09/12/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $19.53 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
09/11/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $13.66 General
Category: RESPIRATORY
09/11/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $9.58 General
Category: Immunology
08/22/2024 Avadel CNS Pharmaceuticals, LLC LUMRYZ (Drug) Food and Beverage In-kind items and services $18.96 General
Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY
08/21/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $18.68 General
Category: INFLAMMATION AND IMMUNOLOGY
08/16/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Food and Beverage In-kind items and services $13.79 General
Category: Cardiology
08/14/2024 Philips North America LLC (AK6) Vest Therapy (Device) Food and Beverage Cash or cash equivalent $16.44 General
Category: Medical Device
06/25/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $16.75 General
Category: CARDIOVASCULAR
06/12/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $14.76 General
Category: RESPIRATORY
05/22/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Food and Beverage In-kind items and services $13.73 General
Category: Cardiology
05/20/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $15.59 General
Category: RESPIRATORY
05/17/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Food and Beverage In-kind items and services $16.43 General
Category: Cardiology
04/24/2024 Philips North America LLC (AK6) Vest Therapy (Device) Food and Beverage Cash or cash equivalent $19.08 General
Category: Medical Device
04/19/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Food and Beverage In-kind items and services $14.53 General
Category: Cardiology
03/15/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Food and Beverage In-kind items and services $15.56 General
Category: Cardiology
03/13/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $13.30 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 320 402 $133,953 $50,620
2022 5 191 240 $66,662 $26,003
2021 6 228 303 $88,491 $32,127
2020 12 354 530 $128,362 $44,742
Total Patients
1,093
Total Services
1,475
Medicare Billing
$153,492
Procedure Codes
32

All Medicare Procedures & Services

32 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 108 164 $75,932 $28,363 37.4%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 41 41 $17,302 $5,866 33.9%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 36 44 $9,592 $4,285 44.7%
99292 Critical care, each additional 30 minutes Facility 2023 31 39 $9,087 $3,468 38.2%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 42 47 $7,144 $2,967 41.5%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 21 22 $6,336 $2,277 35.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 14 18 $5,058 $1,952 38.6%
36556 Insertion of non-tunneled central venous tube for infusion (5 years or older) Facility 2023 13 13 $2,340 $902.98 38.6%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 14 14 $1,162 $537.55 46.3%
99291 Critical care, first 30-74 minutes Facility 2022 52 74 $34,558 $13,528 39.1%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 71 97 $14,841 $5,784 39.0%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 32 32 $9,248 $3,537 38.3%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 25 25 $5,375 $2,099 39.1%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 11 12 $2,640 $1,055 40.0%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 64 94 $46,498 $16,773 36.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 49 63 $14,096 $5,522 39.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 61 92 $13,783 $5,076 36.8%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 28 28 $8,090 $2,885 35.7%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2021 15 15 $3,675 $1,033 28.1%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2021 11 11 $2,349 $837.46 35.7%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 49 112 $61,824 $19,677 31.8%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 127 226 $32,996 $12,798 38.8%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 32 35 $9,590 $3,752 39.1%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 16 21 $6,048 $2,223 36.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 24 29 $6,235 $2,059 33.0%

About Dr. John Kern, DO

Dr. John Kern, DO is a Internal Medicine healthcare provider based in Pomona, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1588930879.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Kern, DO has received a total of $1,838 in payments from pharmaceutical and medical device companies, with $668.33 received in 2024. These payments were reported across 57 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,820).

As a Medicare-enrolled provider, Kern has provided services to 1,093 Medicare beneficiaries, totaling 1,475 services with total Medicare billing of $153,492. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Critical Care Medicine, Pulmonary Disease
  • Location Pomona, NJ
  • Active Since 03/30/2012
  • Last Updated 04/12/2022
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1588930879

Products in Payments

  • UPTRAVI (Drug) $251.01
  • Adempas (Drug) $229.90
  • DUPIXENT (Biological) $192.73
  • OPSUMIT (Drug) $189.47
  • AIRSUPRA (Drug) $113.56
  • FLOWTRIEVER CATHETER, S (Device) $107.18
  • OFEV (Drug) $86.63
  • FASENRA (Biological) $54.21
  • LifeVest (Device) $51.92
  • TRELEGY ELLIPTA (Drug) $44.01
  • HemoSphere (Device) $41.92
  • (AK6) Vest Therapy (Device) $35.52
  • ARALAST (Biological) $30.78
  • NUCALA (Biological) $28.17
  • FUROSCIX (Drug) $23.88
  • Impella (Device) $22.39
  • TYVASO (Drug) $19.53
  • LUMRYZ (Drug) $18.96
  • (8874) inCourage (Device) $16.94
  • VERQUVO (Drug) $16.75

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Pomona